TrialDiabetes care2012

The TOSCA.IT trial: a study designed to evaluate the effect of pioglitazone versus sulfonylureas on cardiovascular disease in type 2 diabetes.

Olga Vaccaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.